Matsyura Oksana, Besh Lesya, Jefimova Svitlana, Khrystyna Slivinska-Kurchak, Gerasymov Sergiy
Danylo Halytsky Lviv National Medical University, Lviv, Ukraine Communal Nonprofit Enterprise "City Children's Clinical Hospital of Lviv", Lviv, Ukraine.
Communal Nonprofit Enterprise "City Children's Clinical Hospital of Lviv", Lviv, Ukraine.
Acta Med Litu. 2024;31(1):12-21. doi: 10.15388/Amed.2024.31.1.2. Epub 2024 Feb 27.
Hematohidrosis (bloody sweat) is a symptom of trophic damage to the vascular wall, in which sweat mixes with blood and seeps onto undamaged areas of the skin in the form of red or pink liquid (depending on the ratio of sweat to blood). In our study we have analyzed 25 case reports of hematohidrosis in children, reported throughout the world using PubMed, ResearchGate with detailed description and opened access. We took into consideration: age of the patient, sex, location of bloody excretion, cause or trigger, treatment and its effectiveness. Our clinical case present a 9-year-old girl complained of a periodic bleeding from the intact skin of the face, neck, thighs (without visible damage to the skin) manifested by red or pink liquid, nosebleeds, and bloody discharge from the mucous membrane of the eyes. The secretions were of varying intensity and lasted up to several hours. Most of all episodes are associated with a strong emotional exertion. One of the theories of hematohidrosis pathogenesis is evident vasoconstriction of the blood vessels surrounding the sweat glands, provoked by hyperactivation of the sympathetic nervous system, which is followed by their excessive vasodilation up to rupture and blood entering the sweat gland ducts. Capillary endothelial cells are known to contain β2-adrenoceptors, which, through the modulation of nitric oxide release, cause endothelium-dependent vasodilation. Blocking β-adrenoceptors (for example, propranolol) prevents excessive vasodilation of blood vessels and, accordingly, their rupture and blood flow to the sweat gland. We managed to find out that the patient's bloody sweat was a manifestation of a separate pathological phenomenon, and not one of the symptoms of another disease. A properly formed treatment complex and the great trust of the parents enabled to stabilize the child's condition, and later to cure her. Currently, hematohidrosis is recognized as an independent disease that requires in-depth study of the triggering mechanisms of development, pathogenetic and clinical features.
血汗症(血性出汗)是血管壁营养性损伤的一种症状,汗液与血液混合,并以红色或粉红色液体的形式(取决于汗液与血液的比例)渗到未受损的皮肤区域。在我们的研究中,我们分析了通过PubMed、ResearchGate检索到的世界各地报道的25例儿童血汗症病例报告,这些报告均有详细描述且可公开获取。我们考虑了:患者年龄、性别、血性分泌物的部位、病因或诱因、治疗方法及其效果。我们的临床病例是一名9岁女孩,她主诉面部、颈部、大腿完好皮肤(皮肤无可见损伤)周期性出血,表现为红色或粉红色液体、鼻出血以及眼黏膜血性分泌物。分泌物强度各异,持续长达数小时。大多数发作与强烈的情绪波动有关。血汗症发病机制的一种理论是,交感神经系统过度激活引发汗腺周围血管明显收缩,随后血管过度扩张直至破裂,血液进入汗腺导管。已知毛细血管内皮细胞含有β2 - 肾上腺素能受体,通过调节一氧化氮释放引起内皮依赖性血管舒张。阻断β - 肾上腺素能受体(例如普萘洛尔)可防止血管过度扩张,从而防止血管破裂和血液流向汗腺。我们发现该患者的血汗症是一种独立病理现象的表现,而非其他疾病的症状之一。合理制定的治疗方案以及家长的高度信任使患儿病情得以稳定,随后治愈。目前,血汗症被认为是一种独立疾病,需要深入研究其发病触发机制、病理和临床特征。